Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey
Nicolas Girerd(Inserm), Patrick Rossignol(Inserm), Laurent Sebbag(Hospices Civils de Lyon), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), David Kénizou(Hôpital Émile-Roux), B Maillier(Centre Hospitalier de Troyes), Marie‐France Seronde(Centre Hospitalier Universitaire de Besançon), James L. Januzzi(Massachusetts General Hospital), Pascal Bilbault(Université de Strasbourg), William T. Abraham(Lung Institute), Tahar Chouihed(Centre Hospitalier Régional et Universitaire de Nancy), Alexandre Mebazaa(Délégation Paris 5), François Braun(Hôpital Femme Mère Enfant), Pierre Nazeyrollas(Centre Hospitalier Universitaire de Reims), G Roul(Hôpital Civil, Strasbourg), Stefano Coiro(University of Perugia), Ludivine Fillieux(Novartis (France))
Cited by 271
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k